One of the things that makes developing effective treatments for Parkinson’s disease so challenging is its complexity.
Labcorp backs Adela’s $48M Series A1 to advance methylation-based head and neck cancer test
Adela has raised $48 million in a Series A1 round backed by new investor and diagnostic giant Labcorp to fund a test for monitoring minimal